CATALOGO DEI PRODOTTI DELLA RICERCA

BENCIVENGA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.524
EU - Europa 4.386
AS - Asia 3.403
SA - Sud America 518
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 168
OC - Oceania 13
Totale 13.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.400
RU - Federazione Russa 2.067
SG - Singapore 1.342
CN - Cina 897
GB - Regno Unito 551
IT - Italia 534
BR - Brasile 415
VN - Vietnam 378
HK - Hong Kong 288
SE - Svezia 225
IE - Irlanda 223
DE - Germania 219
FR - Francia 187
KR - Corea 116
FI - Finlandia 115
BD - Bangladesh 86
JP - Giappone 63
CA - Canada 62
UA - Ucraina 50
ES - Italia 46
IN - India 39
AR - Argentina 38
NL - Olanda 38
ID - Indonesia 35
MX - Messico 35
ZA - Sudafrica 33
AT - Austria 31
TG - Togo 24
IQ - Iraq 22
NG - Nigeria 22
RW - Ruanda 22
BJ - Benin 20
PL - Polonia 20
IL - Israele 18
TR - Turchia 18
BE - Belgio 16
EC - Ecuador 14
UZ - Uzbekistan 13
AU - Australia 12
LT - Lituania 12
PK - Pakistan 12
PY - Paraguay 12
CL - Cile 10
CO - Colombia 10
DZ - Algeria 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
KG - Kirghizistan 7
PH - Filippine 7
PT - Portogallo 7
TW - Taiwan 7
VE - Venezuela 7
EG - Egitto 6
GR - Grecia 6
HN - Honduras 6
SA - Arabia Saudita 6
CR - Costa Rica 5
KE - Kenya 5
MA - Marocco 5
NO - Norvegia 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
LV - Lettonia 4
MY - Malesia 4
TN - Tunisia 4
AL - Albania 3
AO - Angola 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
LK - Sri Lanka 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
CM - Camerun 2
DK - Danimarca 2
ET - Etiopia 2
IR - Iran 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
Totale 13.000
Salva come PNG Salva come JPEG
Città #
Singapore 712
Moscow 697
Ashburn 669
San Jose 482
Southend 413
Chandler 407
Dallas 385
Hong Kong 282
Verona 272
Dublin 219
Beijing 177
Jacksonville 158
The Dalles 153
New York 139
Council Bluffs 138
Ho Chi Minh City 126
Los Angeles 125
Ann Arbor 93
Redmond 78
Woodbridge 74
Hanoi 71
Munich 70
Houston 69
Lawrence 62
Princeton 62
Helsinki 61
Tokyo 57
Jinan 56
São Paulo 50
Wilmington 48
Nanjing 45
Buffalo 40
Santa Clara 39
Shenyang 38
Milan 37
London 36
Redondo Beach 33
Columbus 32
Seoul 30
Hebei 27
Sindelfingen 27
Atlanta 26
Tianjin 26
Amsterdam 24
Dong Ket 24
Lomé 24
Orem 23
Frankfurt am Main 22
Jakarta 22
Kigali 22
Abuja 21
Guangzhou 21
Brooklyn 20
Changsha 20
Cotonou 20
Seattle 19
Johannesburg 18
San Francisco 18
Vienna 18
Chicago 17
Denver 17
Haikou 17
Brussels 16
Falls Church 16
Madrid 16
Mexico City 16
Stockholm 16
Lappeenranta 15
Montreal 15
Nanchang 15
Nuremberg 15
Toronto 15
Turku 15
Warsaw 15
Chennai 14
Haiphong 14
Ningbo 14
Taizhou 14
Zhengzhou 14
Washington 13
Belo Horizonte 12
Hangzhou 12
Manchester 12
Paris 12
Rome 12
Jiaxing 11
Shanghai 11
Tashkent 11
Boston 10
Da Nang 10
Phoenix 10
Rio de Janeiro 10
Baghdad 9
Falkenstein 9
Fuzhou 9
Poplar 9
Ankara 8
Biên Hòa 8
Boardman 8
Bologna 8
Totale 7.697
Salva come PNG Salva come JPEG
Nome #
Genomic characterization of hepatoid tumors: context matters 261
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 229
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 227
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 213
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 209
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 208
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 207
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 203
Methylation Dynamics of RASSF1A and Its Impact on Cancer 199
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 197
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 196
Clinical pathways in gastric cancer care 194
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 189
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 188
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 183
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 183
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 180
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 179
Short-term and long-term risk factors in gastric cancer 178
Lymphadenectomy for gastric cancer at European specialist centres 178
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 176
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 173
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 169
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 162
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 161
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 161
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 159
Complications after gastrectomy for cancer: Italian perspective 156
Western strategy for EGJ carcinoma 154
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 153
Management of critically ill surgical patients Case reports 152
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 151
Tailored treatment for signet ring cell gastric cancer 151
Personalized therapeutic strategies in HER2-driven gastric cancer 151
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 150
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 150
Lymphadenectomy: how to do it? 148
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 147
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 146
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 143
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 143
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 142
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 142
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 138
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 138
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 137
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 137
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 136
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 136
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 135
An aggressive early gastric cancer: Kodama's PenA type 135
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 132
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 129
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 128
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 127
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 125
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 124
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 123
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 123
Surgical treatment of hepatic metastases from gastric cancer 116
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 115
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 114
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 114
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 111
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 111
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 108
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 108
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 108
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 107
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 107
Genomic events stratifying prognosis of early gastric cancer 105
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 104
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 102
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 99
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 93
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 92
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 89
Prophylactic Total Gastrectomy: Techniques 88
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 86
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 84
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden 84
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 81
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 80
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 80
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 80
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 79
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 77
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 77
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 75
Association between ERAS protocol and major postoperative complications and reasons for non-compliance in patients with esophageal cancer 72
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 68
International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning 65
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 65
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 62
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 59
Upper Gastrointestinal Bleeding 55
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment 48
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study 31
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO 30
Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study 28
Totale 13.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.581
article - articoli 46.949
book - libri 0
conference - conferenze 494
curatela - curatele 0
other - altro 684
patent - brevetti 0
selected - selezionate 0
volume - volumi 454
Totale 97.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/20252.055 94 97 93 343 103 69 163 123 279 172 164 355
2025/20266.825 414 326 428 1.200 1.736 421 635 394 548 420 155 148
2026/2027127 101 26 0 0 0 0 0 0 0 0 0 0
Totale 13.208